Akèy › Sipwa › Ohio › Columbus
Etid klinik pou Sipwa nan Columbus, OH
13 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Columbus (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Ap rekriteFaz 3
- Centricity Research - Ohio, Columbus
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Ap rekriteFaz 3
- Remington-Davis, Inc, Columbus
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
Ap rekriteFaz 1
- Ohio Clinical Trials, Columbus
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Ap rekriteFaz 3
- Research Site, Columbus
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Ap rekriteFaz 3
- Nationwide Children's Hospital, Columbus
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Endocrinology Associates Inc, Columbus
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Columbus
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 3
- AURORA-1 Clinical Site, Columbus
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Ap rekriteFaz 3
- Remington Davis Inc, Columbus
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Ap rekriteFaz 3Volontè an sante akeyi
- ACCOMPLISH-2 Research Site, Columbus
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Ap rekriteFaz 3
- Research Site, Columbus
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Ap rekriteFaz 3
- ACCOMPLISH-1 Research Site, Columbus
- ACCOMPLISH-1 Research Site, Columbus
Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
Ap rekriteEtid obsèvasyon
- The Ohio State University, Columbus
Etid Sipwa nan lòt vil
- Houston, TX33 etid
- San Antonio, TX33 etid
- Chicago, IL28 etid
- Orlando, FL25 etid
- Miami, FL23 etid
- Las Vegas, NV23 etid
- Dallas, TX20 etid
- Atlanta, GA20 etid
- New York City, NY19 etid
- Jacksonville, FL19 etid
- Washington, DC19 etid
- Austin, TX18 etid
Lòt etid nan Columbus
- Kansè Poumon ki pa ti selil55 etid
- Kansè (tout kalite)39 etid
- Kansè nan tete39 etid
- Kansè ovè39 etid
- Kansè poumon36 etid
- Leksemi mieloïd egi34 etid
- Lukemi lenfositè kwonik29 etid
- Kansè Metastatik27 etid
- Kansè Endomèt26 etid
- Kansè kolorektal24 etid
- Myelom Miltip24 etid
- Kansè pwostat24 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.